Announcements Trials

Browse Landscape

Phase

Phase 2 1 Phase 1 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 33 Leukemia, Myeloid, Acute 26 Colorectal Neoplasms 26 Neoplasms 24 Neoplasm Metastasis 23 Recurrence 22 Multiple Myeloma 22 Advanced Solid Tumors 19 Lymphoma, B-Cell 18 Breast Neoplasms 18 Lung Neoplasms 14 Pancreatic Neoplasms 13 Glioblastoma 13 Melanoma 12 Hematologic Neoplasms 12 Carcinoma, Hepatocellular 12 Lymphoma 11 Glioma 11 Brain Neoplasms 11 Squamous Cell Carcinoma of Head and Neck 10 Precursor Cell Lymphoblastic Leukemia-Lymphoma 10 Leukemia 10 Advanced Solid Tumor 10 Prostatic Neoplasms 9 Ovarian Neoplasms 9 Head and Neck Neoplasms 9 Triple Negative Breast Neoplasms 8 Lymphoma, Non-Hodgkin 8 Lymphoma, Large B-Cell, Diffuse 8 Esophageal Neoplasms 8

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Not yet recruiting × mCRC × Clear all

NCT07543471 2026-04-24

PK similarity

Shanghai Henlius Biotech

Phase 1 Not yet recruiting

mCRC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡